---
title: "Citi Sticks to Its Buy Rating for Glaukos (GKOS)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292048170.md"
description: "Citi analyst Joanne Wuensch reiterated a Buy rating on Glaukos (GKOS) with a $175 price target. The stock closed at $148.70. Analyst consensus remains a Strong Buy with an average target of $160.60, implying 8% upside. Additionally, H.C. Wainwright initiated coverage with a Buy rating and a $168 target."
datetime: "2026-07-08T09:46:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292048170.md)
  - [en](https://longbridge.com/en/news/292048170.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292048170.md)
generator: "portal-rs"
---

# Citi Sticks to Its Buy Rating for Glaukos (GKOS)

Citi analyst Joanne Wuensch reiterated a Buy rating on Glaukos on July 6 and set a price target of $175.00. The company’s shares closed yesterday at $148.70.

### 4th of July Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

Wuensch covers the Healthcare sector, focusing on stocks such as Integra Lifesciences, Abbott Laboratories, and Edwards Lifesciences. According to TipRanks, Wuensch has an average return of 1.3% and a 52.74% success rate on recommended stocks. 

Currently, the analyst consensus on Glaukos is a Strong Buy with an average price target of $160.60, representing an 8.00% upside. In a report released on July 6, H.C. Wainwright also initiated coverage with a Buy rating on the stock with a $168.00 price target.

### Related Stocks

- [GKOS.US](https://longbridge.com/en/quote/GKOS.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [IART.US](https://longbridge.com/en/quote/IART.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [EW.US](https://longbridge.com/en/quote/EW.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [Glaukos (GKOS), Why Is The Story Getting Harder To Ignore?](https://longbridge.com/en/news/296739885.md)
- [Glaukos director Gilbert H. Kliman disposes of 2,500 common shares for $475,000](https://longbridge.com/en/news/296547975.md)
- [Glaukos management to participate in Wells Fargo Healthcare Conference](https://longbridge.com/en/news/296343630.md)
- [California State Teachers Retirement System Purchases 11,871 Shares of Glaukos Corporation $GKOS](https://longbridge.com/en/news/295071518.md)
- [Walleye Capital LLC Takes $3.75 Million Position in Glaukos Corporation $GKOS](https://longbridge.com/en/news/295998885.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**